Drug Type Enzyme |
Synonyms CM AT, CMAT |
Target |
Mechanism Enzymes modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autistic Disorder | NDA/BLA | US | - |
Phase 3 | 190 | (CM-AT) | srqgvheunv(fxfnumwwvg) = gdwlmtkqfc qaqdwohglc (jivvjlbjus, apeetvlkle - ghkdwmuarb) View more | - | 26 Oct 2022 | ||
PLACEBO (Placebo) | srqgvheunv(fxfnumwwvg) = wwzqdfqabn qaqdwohglc (jivvjlbjus, kwryatdnty - qemcmldirg) View more |